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Introduction
The blood-brain barrier is a highly selective, semipermeable interface regulating the passage of ions and larger molecules into the extracellular matrix of the CNS and thereby playing a crucial role in maintaining strict neuronal homeostasis (Obermeier et al., 2013) . The association between epilepsy and the blood-brain barrier has long been suggested (Jasper, 1970) ; however, epilepsy research has faced a crucial question since then: whether the blood-brain barrier dysfunction is a cause or a consequence of epileptic seizures or both (Friedman, 2012) . There is a burgeoning body of evidence including animal and patient studies supporting that a dysfunction of the blood-brain barrier contributes to epileptogenesis (Fieschi et al., 1980; Zappulla et al., 1985a, b; Seiffert et al., 2004; Ivens et al., 2007; van Vliet et al., 2014 van Vliet et al., , 2016 Weissberg et al., 2015; Bar-Klein et al., 2017) . Conversely, blood-brain barrier dysfunction has been suggested to be a consequence of epileptic seizures in animal studies (Roch et al., 2002; Librizzi et al., 2012; Vazana et al., 2016) , but evidence remains sparse in animals and is only anecdotally reported in clinical case studies (Horowitz et al., 1992; Hattingen et al., 2008; Alvarez et al., 2010) . There is, thus, a lack of knowledge regarding the peri-ictal modulation of blood-brain barrier permeability in patients, which we try to address with the current study. In patients, contrast-enhanced quantitative MRI has been used to interrogate blood-brain barrier permeability and has been widely shown to have a higher diagnostic value than conventional dynamic-contrast enhanced MRI (Hattingen et al., 2013; Jurcoane et al., 2013; Bourcier et al., 2017) . The basic approach to quantitative MRI is relaxometry, which directly measures the relaxation time instead of the ill-defined signal intensities of conventional MRI (Deoni, 2010; Margaret Cheng et al., 2012; Hattingen et al., 2015) .
In this study, we performed T 1 -relaxometry (qT1) at various time points after both ictal and interictal injection of gadolinium contrast agent in epilepsy patients and contrasted the resulting volumes to quantify postictal enhancement. As a complement, we investigated postictal and interictal serum levels of proteins S100 and MMP9, which are both considered indicators of blood-brain barrier dysfunction (Kapural et al., 2002; Barr et al., 2010) . Our two hypotheses state that blood-brain barrier dysfunction is temporally associated with single epileptic seizures (peri-ictal) in patients (Hypothesis 1) and that more extended epileptic ictal activity would result in anatomically more widespread blood-brain barrier dysfunction (Hypothesis 2). To test Hypothesis 1, we analysed qT1 scans at different time points after both ictal and interictal injection of contrast agent and examined S100 and MMP9. To test Hypothesis 2, we contrasted the results of patients who showed secondarily generalized tonic-clonic seizures (GTCSs) to the results of patients who exhibited focal seizures. The goal of the current study was to image ictally-associated blood-brain barrier dysfunction in epilepsy patients by using a newly established protocol.
Materials and methods

Study design
Twenty-three patients [10 females; mean age AE standard deviation (SD): 28.78 AE 8.45 years] with medically refractory focal epilepsy and undergoing presurgical evaluation for epilepsy surgery at the Department of Epileptology at the University of Bonn Medical Center were included in the study. The patients were prospectively enrolled after they had been admitted to the video-EEG monitoring unit and met the following inclusion criteria: (i) no contraindications to MRI; (ii) age 5 18 years; (iii) no mental disability; (iv) no history of allergic reactions to MRI contrast dyes and kidney disease; and (v) serum creatinine 51 mg/dl. As part of the presurgical evaluation, all patients underwent clinical examinations, video-EEG monitoring including the recording of seizures, neuroradiological MRI, neuropsychological assessment, and routine blood tests. The presumed seizure onset zone was localized based on the summary of all diagnostic results. Nine of 23 patients had no apparent lesion on MRI and were considered magnetic resonance-negative. The presumed seizure onset zone was, in these cases, localized by means of modalities other than MRI. For the purpose of the study, patients underwent a minimum of three MRI sessions: one contrast-enhanced qT1 scan (i.e. T 1 relaxometry) after both ictal and interictal injection of contrast agent, respectively, was conducted additionally to one pre-contrast qT1 scan. Sixteen of 23 patients underwent more than one scan after postictal and interictal injection: seven of these 16 patients underwent two postictal and two interictal qT1 scans. Nine of 16 patients underwent three qT1 scans after both ictal and interictal injection of contrast agent (three postictal and three interictal scans). The injection-to-qT1 time intervals were ensured to be equal for both postictal and interictal scans. Thus, each postictal qT1 volume could be contrasted with interictal qT1 volumes acquired with the same injection-to-qT1 time interval. Interictal qT1 scans were performed a minimum of 2 days after the postictal contrast enhanced qT1-scan and after a clinical seizure-free period of at least 24 h. The pre-contrast qT1 scan was performed at least 2 days after the interictal contrast enhanced qT1 scan and a clinical seizure-free period of at least 12 h. Seizure duration, injection latency, and seizure type were determined retrospectively based on the video-EEG recordings (see Tables 1 and 2 for details) . Accordingly, patients were assigned to either the group of patients who had a secondary GTCS (GTCS group) or to the group of patients who had a focal seizure (FS group). The study was approved by the local Institutional Review Board and all patients provided written informed consent.
Seizure and injection of contrast agent
Gadolinium-based contrast agent causes a shortening of the T 1 time. A standard dose of 7.5 ml (1 mmol/ml) of the gadolinium-based contrast agent gadobutrol (Gadovist Õ ) diluted with 40 ml saline solution was administered to the patient through a peripheral venous catheter. It was followed by 50 ml pure saline solution for flushing. The injection was performed by an automatic contrast injector (CT-Injektor Missouri TM , ulrich medical) and was remotely initiated from the monitoring workstation where the onset of the seizure could be determined by means of EEG and video. After ictal injection, the patient was examined by a physician and transported to the MRI facility as soon as the clinical condition permitted. All patients were medically supervised by a physician during the transport to the MRI facility and the MRI scan. The interictal injection took place in the MRI facility.
Serum samples
Baseline serum samples of 37 patients were drawn at the onset of video-EEG monitoring, prior to the first recorded seizures as well as within the first 30 min after a seizure and 2, 6, 24 and 48 h after the index seizure. Seven of 37 patients were also participants of the imaging part of the current study. In five of 37 patients, a generalized seizure occurred during the timeframe described above. In these cases, a new set of serum sampling was started. Serum samples for MMP9 were stored at À80 C for later analysis using the Human MMP9 Quantikine ELISA Kit Õ (R&D Systems). Serum samples for S100 measurements were centrifuged at 4 C and processed within 48 h. S100 was measured with an electrochemiluminescence assay (ECLIA) on a cobas Õ e 411 modular analyzer (Roche Diagnostics) with the Elecsys Õ S100 reagent kit (Roche Diagnostics).
qT1 image acquisition and processing
Quantitative T 1 maps were acquired on a 3 T MAGNETOM Trio (Siemens Healthineers) using a 32-channel head receive coil and the scanner's body coil for radio frequency transmission. The optimized acquisition protocol was developed by Note that the latency of qT1 acquisition after the onset of the seizure was kept the same for interictal and postictal scans. F = female; FS group = group of patients who had a focal seizure; GTCS group = group of patients who had a generalized tonic-clonic seizure; M = male. Note that the latency of qT1 acquisition after the onset of the seizure was kept the same for interictal and postictal scans. FCD = focal cortical dysplasia; HV = hyperventilation; SOZ = seizure onset zone. Preibisch and Deichmann (2009a, b) . The basic processing steps of the qT1 data were performed using the FMRIB Software Library (FSL) (Smith et al., 2004) and custom-built scripts written in MATLAB (MathWorks Õ ). For detailed information see the online Supplementary material.
qT1 image analysis Regions of interest analysis
Imaging data were analysed using FSL v5.0 (Smith et al., 2004) . First, pre-contrast volumes were skull-stripped, followed by an automated segmentation into three tissue classes (grey matter, white matter, CSF) using FMRIB's Automated Segmentation Tool (Zhang et al., 2001; Smith, 2002) . As accuracy of automated grey matter segmentation tools has been shown to greatly differ between datasets (Eggert et al., 2012) , visual quality control is crucial (Johnson et al., 2017) . Hence, all regions of interest were controlled visually for correct alignment. This was done by superimposing the regions of interest on the native qT1 volumes in native space and inspecting the intersection of the segmented regions of interest with the underlying MRI data. For each subject, postictal and interictal images were co-registered to the pre-contrast volume (Jenkinson et al., 2002) . To calculate the difference map (ÁqT1) indicating T 1 reduction upon contrast agent enhancement after epileptic seizures, postictal qT1 volumes were subtracted voxel-wise from the corresponding interictal qT1 volumes acquired with the same injection-to-qT1 latency. ÁqT1 values were averaged across all voxels belonging to the grey or the white matter mask, respectively, and taken for further analysis. Positive ÁqT1, thus, indicated contrast agent enhancement in the postictal as compared to the interictal qT1 volumes.
Voxel-wise analysis
The exact interindividual alignment is an essential factor in statistical group analyses of voxel-wise approaches. High degreesof-freedom non-linear transformations are commonly used in spatial normalizations (Klein et al., 2009 ). However, inaccuracies and misalignment, especially in cortical grey matter structures, can easily lead to misinterpretations of the underlying data and are subject to an ongoing debate in neuroimaging (Bookstein, 2001; Pruessner et al., 2002; Smith et al., 2006; Lerch et al., 2017) . To mitigate the effects of regional misalignment, spatially normalized images are typically smoothed via convolution with a 4-16 mm full-width at half-maximum Gaussian kernel. As discussed in the original publication by Smith et al. (2006) , smoothing can increase sensitivity if the extent matches the size of the effect to be observed. However, as the spatial extent of postictal T 1 relaxation time differences is unknown, choosing an arbitrary size of a smoothing kernel may mask the effect of interest. Furthermore, qT1 values differ substantially between tissue types (white matter = 900 ms; grey matter = 1400 ms; CSF = 4500 ms), which renders effective partial voluming as crucial problem in statistical analyses. To circumvent the problems mentioned above, a TBSS (tract-based spatial statistics) inspired analysis was conducted (Smith et al., 2006) . While similar approaches have already been used in the analysis of diffusivity parameters (Ball et al., 2013; Nazeri et al., 2015) , we here describe the usage of an adapted grey and white matter skeletonization procedure in the assessment of regional T 1 relaxation time differences. First, non-linear transformation warp fields to 1 Â 1 Â 1 mm 3 MNI152 space were created for precontrast T 1 -weighted volumes. These warp fields were in turn applied to individual partial volume estimates (PVEs), produced by FAST for grey and white matter, and to the ÁqT1 maps. To ensure cross-subject summation of postictal qT1 differences, all spatially normalized maps were flipped in x-direction for patients with the presumed seizure onset zone in the right hemisphere. The transformed PVEs were merged and averaged to create mean grey and white matter PVEs. The resulting mean PVEs were used for skeleton generation as described by Smith et al. (2006) . In our adapted pipeline, the search direction perpendicular to the local grey or white matter surface was determined for every voxel in the image by finding the direction of biggest PVE probability change. By performing non-maximum suppression along the search direction, the mean PVEs were skeletonized to mostly 2D, curved surfaces containing only highly probable grey or white matter voxels, respectively. Local maxima of the spatially normalized individual PVEs were then projected onto the corresponding mean skeleton by searching again along the perpendicular direction for the most probable grey or white matter voxels. The resulting projection vectors were in turn used to fill the skeleton with the aligned ÁqT1 values for statistical analysis. Thereby, we broke down the individual whole-brain ÁqT1 maps to grey and white matter skeletons containing the qT1 differences from the most probable grey and white matter voxels, respectively, without the need of arbitrary smoothing and exact non-linear spatial alignment. See Fig. 1 for a schematic of data acquisition and analysis.
As this TBSS-like approach is experimental, all voxel-wise analyses were repeated applying a standard approach to ensure validity of our results: ÁqT1 maps were carefully normalized to the MNI152 template using the previously computed warp fields and minimally smoothed applying a 3D 2 mm Gaussian kernel. The resulting maps of increased contrast-enhancement spatially coincided with the clusters found in the above-described skeletonization approach, however, did not survive family-wise error (FWE) correction, most likely because of the discussed issue of effective partial voluming.
Statistical analysis Regions of interest analysis
We used STATA 14.2 (StataCorp, College Station, TX) for region of interest analysis and analysis of biomarkers (see above). Accounting for repeated measurements, we used a mixed linear model to estimate and test various effects and interactions. The dependent variable was ÁqT1 and the independent variables were group (GTCS, FS) and injection-to-qT1 latency. The injection-to-qT1 latency was included in the model and controlled for as it highly varied between subjects and directly affects qT1. To yield robust results, we used a bootstrap analysis using 10 000 samples. For details of the statistical analysis of regions of interest see the online Supplementary material.
Voxel-wise analysis
Voxel-wise analysis was conducted using FSL's non-parametric Permutation Analysis of Linear Models (PALM) tool for permutation-based statistical inference (Winkler et al., 2014 (Winkler et al., , 2016 . Here, we set up a two-group comparison, including the demeaned injection-to-qT1 latency as continuous covariate, in which all scan time points were considered. This is achieved by defining exchangeability blocks restricting the permutations between groups on subjects with equal amount of measurements. For FWE correction we performed 2D threshold-free cluster enhancement due to the mostly 2D structure of skeletonized imaging data. FWE-corrected clusters were considered significant at P 5 0.05.
Statistical analysis of MMP9 and S100 serum
For the statistical analysis of MMP9 and S100 serum concentrations, we used a mixed linear model to estimate and test the influence of the time after the onset of the seizure on serum concentration of the respective marker. Results were confirmed by 10 000 bootstrappings.
Data availability
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available as they contain information that could compromise the privacy of research participants.
Results
Clinical group differences
Fifteen patients had secondary GTCS during video-EEG monitoring, whereas eight exhibited focal seizures (FS) only. The mean seizure duration was 51.9 s in the FS group and 86.3 s in the GTCS group (t = À1.7, df = 21, P = 0.091). Groups did not differ significantly in age (t = 0.72, df = 21, P = 0.479), gender ( 2 = 0.21, P = 0.645), number of scans (t = À1.26, df = 21, P = 0.187), latency of injection (t = À0.27, df = 21, P = 0.788), and in the injection-to-qT1 latency of the first scan (t = À1.13, df = 21, P = 0.269). The difference of the injection-to-qT1 latencies between the postictal and the interictal scans was below 8 min for all cases. Visual assessment of the first interictal scans by an expert neuroradiologist (E.H.) did not show any signs of interictal contrast enhancement. Details of the patient groups and of the measurements are provided in Tables 1 and 2 .
Regions of interest ÁqT1 between-group differences
All 23 patients with epilepsy were considered for region of interest analysis. Of those, 16 were scanned more than once, resulting in 48 datasets that equally consisted of postictal and interictal volumes. The GTCS group showed a significantly higher ÁqT1 level in the whole-brain mask (i.e. lower T 1 in the postictal as compared to the interictal volumes) as compared to the FS group [GTCS 4 FS; mean difference AE standard error (SE): 35.97 AE 14.16 ms, 95% CI: 8.22-63.71 ms, z = 2.54, P = 0.011], when controlling for injection-to-qT1 latency. This whole-brain difference was further reflected by significantly higher ÁqT1 in global grey matter (32.68 AE 13.48 ms, 95% CI: 6.25-59.10 ms, z = 2.42; P = 0.015) and white matter (16.86 AE 8.37 ms, 95% CI: 0.45-33.25 ms, z = 2.01, P = 0.044) in the GTCS group as compared to the FS group, when controlling for injection-to-qT1 latency. 
Voxel-wise ÁqT1 between-group differences
For voxel-wise analysis, one patient from the FS group had to be excluded, as the extent of their lesion negatively affected the robustness of the skeletonization process.
GTCS-FS group differences
Considering the full sample and including all scan time points adjusted for injection-to-qT1 latency, we observed widespread clusters indicating higher ÁqT1 in grey and white matter in the GTCS as compared to the FS group (GTCS 4 FS; uncorrected P 5 0.05). Results maintained significance at a threshold of uncorrected P 5 0.001, but are depicted here at a lower threshold for visualization purposes. The inverse contrast (GTCS 5 FS) did not yield any differences in ÁqT1 at a lenient uncorrected 5% significance threshold (Fig. 2) .
Influence of injection-to-qT1 latency on ÁqT1 moderated by group
The effect of injection-to-qT1 latency on ÁqT1 is modified by the group effect (injection-to-qT1 latency Â group interaction; FWE-corrected P 5 0.05) specifically in the hemisphere contralateral to the presumed seizure onset zone. Here, the ÁqT1 decline is substantially faster in the GTCS groups as compared to the FS group (Fig. 3 ).
Early and late scans
To estimate the effect of injection-to-qT1 on ÁqT1, we divided our sample into two subsamples consisting of 'early' (injection-to-qT1 latency 5 90 min, 12 FS versus six GTCS; EARLY subsample) and 'late' scans (injectionto-qT1 latency 4 180 min, seven FS versus seven GTCS; LATE subsample). Both subsamples did not differ significantly in basic parameters (age, gender), whereas in the EARLY subsample, we observed significantly higher ÁqT1 in the GTCS group (GTCS 4 FS; uncorrected P 5 0.05) in grey and white matter of both hemispheres as compared to the FS group (Fig. 4A) . Results maintained significance at a threshold of uncorrected P = 0.001, but are depicted here at a lower threshold for visualization purposes. Analysis of the LATE subsample also revealed higher ÁqT1 in the GTCS group versus the FS group (GTCS 4 FS; FWE corrected P 5 0.05), Here, differences were strictly lateralized to the hemisphere ipsilateral to the presumed seizure onset zone (Fig. 4B) . The inverse contrasts (GTCS 5 FS) did not detect any significant results in both groups.
Increased blood serum concentrations of postictal MMP9 and S100 S100 of 37 datasets and MMP9 of 27 datasets could be determined. Analyses were run separately for the GTCS (MMP9: n = 21; S100: n = 31) and the FS group (MMP9 and S100: n = 6). For both serum markers, the mixed linear model identified a significant main effect of the time after the onset of the seizure on blood serum levels in the GTCS group (MMP9: df = 5, 2 = 24.53, P = 0.0002; S100: df = 5, 2 = 24.53, P = 0.0002). MMP9 concentration was significantly elevated directly after the seizure (mean difference AE SE: 243.95 AE 89.04 ng/ml, 95% CI: 69.43-418.46 ng/ml, z = 2.74, P = 0.006). An increased level was still observed 2 h (265.06 AE 89.04 ng/ml, 95% CI: 90.54-439.57 ng/ml, z = 2.98, P = 0.003) and 6 h (358.34 AE 89.04 ng/ml, 95% CI: 183.82-532.86 ng/ml, z = 4.02, P 5 0.001) after seizure (Fig. 5A) . S100 blood serum concentrations were significantly elevated directly after the seizure (mean difference AE SE: 0.05 AE 0.01 mg/l, 95% CI: 0.03-0.07 mg/l, z = 4.28, P 5 0.001) but dropped to baseline 2 h afterwards (SE: 0.01 AE 0.01 mg/l, 95% CI: 0.03-0.03 mg/l, z = 1.03, P = 0.304) (Fig. 5B) . In the FS group, both MMP9 and S100 showed similar trends, but differences did not reach statistical significance. Detailed information of pairwise comparisons and confidence intervals can be found in Supplementary Table 2 .
Discussion
This study yields two main findings. First, blood-brain barrier dysfunction in epilepsy is temporally (Hypothesis 1) and anatomically (Hypothesis 2) associated with epileptic seizures. Second, this ictally-associated blood-brain barrier dysfunction may be measured by a new quantitative MRI protocol, which contrasts volumes resulting from T 1 -relaxometry after both ictal and interictal injection of gadolinium-based contrast agent. compared to all scan time points of the FS group (GTCS 4 FS; uncorrected P 5 0.05). Results maintained statistical significance at a threshold of uncorrected P 5 0.001, but are depicted here at a more lenient threshold for visualization purposes. Increases are displayed onto white and grey matter skeletons of the full sample (green). Right: Statistical images were rendered and visualized on the 3D volume of the MNI152 template. ant = anterior; inf = inferior; pos = posterior; pSOZ = presumed seizure onset zone; sup = superior.
ÁqT1 as functional imaging marker
Our imaging protocol allowed us to scrutinize what has been termed 'transient postictal MRI signal changes' (Yaffe et al., 1995; Hattingen et al., 2008; Cianfoni et al., 2013) . These signal changes may reflect altered perfusion, oedema, and blood-brain barrier dysfunction. Here, we sensitized our MRI protocol to alterations in vascular integrity after injection of gadolinium-based contrast agent. Quantitative T 1 -mapping applied in the current study has been proven to be even more sensitive in the detection of contrast agent enhancement than conventional MRI (Hattingen et al., 2013; Jurcoane et al., 2013; Bourcier et al., 2017) . By comparing postictal to interictal quantitative volumes, subtle extravascular enhancements of contrast agent shall, thus, be detected. Also, intravascular contrast agent is detected, which influences ÁqT1 in case of postictal alterations in perfusion. Hypoperfusion has been described to occur postictally (Leonhardt et al., 2005; Von Oertzen et al., 2011; Gaxiola-Valdez et al., 2017) , leading to potentially less contrast agent in the postictal as compared to the interictal scans. Our results, however, are indicative of more contrast agent in the postictal as compared to the interictal scans.
Thus, it appears likely that positive ÁqT1 stems from extravascular (as opposed to intravascular) contrast agent. The fact that positive ÁqT1 is found several hours after the onset of seizure points in the same direction (see next paragraph). It should be noted that the results of the full sample and the early subsample (Figs 2 and 4A) in contrast to the results of the interaction analysis and the late subsample (Figs 3 and 4B) do not survive correction for multiple comparison. Therefore, caution is warranted when interpreting them, and our claims are more firmly substantiated by the FWE-corrected results. The reason for the full sample and the early subsample results not surviving correction for multiple comparison may lie in the signal alteration of qT1 by postictal hypoperfusion increasing the statistical spread of data in the between-groups tests. It is known that postictal hypoperfusion normalizes after more than 90 min (GaxiolaValdez et al., 2017) .
Temporal seizure-association of ÁqT1: Hypothesis 1 Transient postictal MRI signal changes have been described minutes to hours after the seizure (Cianfoni et al., 2013) . A recent study could clearly delineate postictal hypoperfusion by means of arterial spin labelling in the vicinity of the seizure onset zone (Gaxiola-Valdez et al., 2017) up to 90 min after the seizure. In the current study, we found higher ÁqT1 in the GTCS group as compared to the FS group more than 180 min after ictal injection. This corroborates our interpretation of ÁqT1 as indicator of (extravascular) enhancement of contrast agent. Furthermore, clusters appeared to be more delineated in the hemisphere ipsilateral to the presumed seizure onset zone in later as compared to earlier scans (Fig. 4) . Possibly, this reflects the effect of postictal hypoperfusion normalizing more than 90 min after seizure onset. The injection-to-qT1 latency Â group interaction needs additional mentioning: interestingly, it is specifically observed in the hemisphere contralateral to the presumed seizure onset zone thought to be only compromised by ictal epileptic activity in the GTCS group. Here ÁqT1 decays as a function of time, whereas it does not in the FS group, in which seizure activity was restricted to the hemisphere ipsilateral to the presumed seizure onset zone. We believe this to be a washout effect of extravascular contrast agent indicating contralateral blood-brain barrier dysfunction only in the GTCS group. The serum concentration of gadolinium has been shown to halve within 3.5 h (Aime et al., 2009) in healthy subjects. Despite this relatively short plasma elimination half-life, the finding of significant between-group differences more than 180 min after seizure onset leaves a large time window for the detection of postictal gadolinium enhancement in grey matter. However, it should be clearly stated that the onset of the postictal blood-brain barrier dysfunction may not exactly be defined by the imaging part of the current study. All injections have started a minimum of 14 s and on average 49.3 s (SD: 40.1) before the end of the seizure (Table 1) . Based on dynamic contrast-enhanced MRI, we know that it takes 5-10 s before the contrast agent reaches the brain following injection to a peripheral vein. We, thus, assume that gadolinium accumulates in the ictal brain in all cases. However, blood-brain barrier dysfunction could occur during the seizure or at any time Figure 4 Early and late scans. (A) The early subsample shows significantly higher ÁqT1 (hot colours) in both hemispheres of the GTCS group as compared to the FS group (GTCS 4 FS; uncorrected P 5 0.05). Results maintained statistical significance at a threshold of uncorrected P 5 0.001, but are depicted here at a more lenient threshold for visualization purposes. (B) Supra-threshold voxels of the same contrast in the late subsample are only found in the hemisphere ipsilateral to the presumed seizure onset zone (GTCS 4 FS; FWE-corrected P 5 0.05). Corresponding results are displayed on the white and grey matter skeleton of the early (yellow) and late (blue) subsample. Statistical images were rendered and visualized on the 3D volume of the MNI152 template. con = contralesional hemisphere; inf = inferior; les = lesional hemisphere; pSOZ = presumed seizure onset zone; sup = superior.
postictally before qT1 acquisition. The analysis of serum markers is more informative in this regard as it shows a direct postictal increase of S100 serum levels and, thus, in accordance with results of animal studies (Vazana et al., 2016) , indicates an immediate postictal blood-brain barrier affection. The contrast of postictally and interictally acquired scans ensures that only transient and ictallyassociated alterations of blood-brain barrier permeability will be imaged. Epileptogenic lesions are known to exhibit signs of permanent/interictal blood-brain barrier dysfunction (Marchi et al., 2012) . These could not be demonstrated by visual expert assessment of interictal volumes in the current sample, which, however, is not as sensitive as quantitative analysis. It is, thus, important to note that additional to the peri-ictal blood-brain barrier dysfunction found here, interictal blood-brain barrier dysfunction may occur.
Anatomical seizure-association of ÁqT1: Hypothesis 2 By comparing patients with GTCS to patients with FS, we aimed to test the hypothesis that postictal blood-brain barrier dysfunction is directly linked to the anatomical spread of ictal epileptic activity. Whereas focal seizures compromise variant anatomical parts of the hemisphere ipsilateral to the presumed seizure onset zone, secondarily generalized tonic-clonic seizures are thought to affect both hemispheres. Correspondingly, clusters indicating between-group differences in ÁqT1 are found globally. Clusters indicating scan-latency Â group interaction and late between-group differences in ÁqT1 (Figs 3 and 4B ) are strictly located in the hemispheres contralateral and ipsilateral to the presumed seizure onset zone, respectively, most likely indicating preceding ictal epileptic activity in the GTCS as Figure 5 Blood serum biomarker analysis. Blood serum concentrations of (A) MMP9 (ng/ml) and (B) S100 (mg/l) as a function of time postonset of the seizure in the GTCS group. Boxplots display the sample mean and extend from 25th to 75th percentile. Whiskers correspond to approximately AE 2.7 SD. Asterisks indicate significance of pairwise comparisons based on mixed model. ÃÃ P 5 0.01, ÃÃÃ P 5 0.001.
compared to the FS group. It is subject to our ongoing studies to show whether these effects also persist on an individual level and can, thereby, be used to localize the seizure onset zone in a diagnostic setting. When using the TBSSlike approach for individual-level analysis, maximal contrast agent enhancement was found in the vicinity of the presumed seizure onset zone in some cases (Fig. 6A) , whereas no region of maximal contrast agent enhancement could be found in other cases (Fig. 6B) . At this state, it is unclear which factors determine whether contrast agent enhancement reflecting ictal activity can be used to delineate the presumed seizure onset zone. Importantly, maximal contrast agent enhancement could be found in the vicinity of the presumed seizure onset zone in a nonlesional patient (Patient 1 in Fig. 6 ). It is obvious that magnetic resonance-negative patients would particularly benefit from an imaging protocol geared towards visualizing ictal activity instead of epileptogenic lesions.
S100 and MMP9 as serum markers
Increased postictal serum levels of S100 and MMP9 corroborate our interpretation of between-group differences in ÁqT1 as indicative of blood-brain barrier dysfunction. Furthermore, they replicate the results of previous studies (Kapural et al., 2002; Li et al., 2013; Ljubisavljevic et al., 2015) . The early increase of S100 observed minutes after the seizure is a strong argument that the contrast agent enhancement seen in MRI relates to a blood-brain barrier dysfunction occurring during the seizure or shortly after. Of note, this is not contradicted by the delayed increase of MPP9, which is known to reflect blood-brain barrier dysfunction only hours after it occurred (Li et al., 2013) . Most interestingly, a recent animal study has found MMP to play a functional role in the mediation of peri-ictal blood-brain barrier dysfunction (Rempe et al., 2018 ). 
Conclusion and outlook
The current study provides evidence for the occurrence of a blood-brain barrier dysfunction that is temporally (Hypothesis 1) and anatomically (Hypothesis 2) associated with epileptic seizures. Quantitative T 1 after ictal contrast agent injection is shown to be a valuable imaging marker of peri-ictal blood-brain barrier dysfunction several hours after onset of the seizure. However, to date it is unclear whether these measurements will also be successful on an individual level. Nonetheless, the current study could be a first stepping stone on the way to complement epilepsy imaging by seizure imaging. Future studies may be able to post hoc measure ictally-associated blood-brain barrier dysfunction in individual patients, thereby visualizing the traces of single epileptic seizures and localizing their origin (Rü ber et al., 2018) . The imaging protocol introduced in this study could, thereby, become a diagnostic modality in presurgical evaluation of epilepsy patients, where it would be of particular importance for non-lesional epilepsy patients. A better understanding of the peri-ictal blood-brain barrier dysfunction may, furthermore, inspire novel therapies exploiting peri-ictal drug infusion (Henshall et al., 2016; Vazana et al., 2016) for enhanced focal drug delivery in brain regions affected by epilepsy.
